These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 928807)

  • 1. [The general discription of the population of the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D. (author's transl)].
    Rywik S; Charzewska J; Napierala M; Bieganowska K; Wagrowska H; Szostak WB; Michalski E
    Przegl Lek; 1977; 34(8):615-20. PubMed ID: 928807
    [No Abstract]   [Full Text] [Related]  

  • 2. [The frequency of cardiovascular symptoms in the male population aged 40-59 from the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D.(author's transl)].
    Rywik S; Charzewska J; Napierala M; Szostak WB; Wagrowska H; Bieganowska K; Michalski E
    Przegl Lek; 1977; 34(8):621-5. PubMed ID: 928808
    [No Abstract]   [Full Text] [Related]  

  • 3. [The distribution of serum cholesterol level in the male population aged 40-59 covered by the Polish trial on multifactorial prevention of IHD (first pair of the Warsaw factories) (author's transl)].
    Chotkowska E; Rywik S; Szostak WB; Napierala M
    Przegl Lek; 1977; 34(8):627-30. PubMed ID: 928809
    [No Abstract]   [Full Text] [Related]  

  • 4. [The risk factors level and its inter-regional variations in the population covered by the Polish trial on multifactorial prevention of I.H.D. (author's transl)].
    Charzewska J; Rywik S; Szostak WB; Chotkowska E; Chabros E; Sznajd J; Magdoń M; Koblik T; Olszanecki S; Pajak A
    Przegl Lek; 1979; 36(10):715-22. PubMed ID: 515455
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prevalence of hypercholesterolemia in the male population covered by Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Rywik S; Szostak WB; Charzewska J; Sznajd J; Wasowicz B; Magdoń M; Nowacki G
    Przegl Lek; 1979; 36(10):737-41. PubMed ID: 515458
    [No Abstract]   [Full Text] [Related]  

  • 6. [Population included in the programme for prevention of coronary heart disease (author's transl)].
    Sznajd J; Rywik S; Kiec E; Magdoń M; Pach J; Kowal S; Olszanecki S; Ryskala Z
    Przegl Lek; 1976; 33(6):599-605. PubMed ID: 959611
    [No Abstract]   [Full Text] [Related]  

  • 7. [The prevalence of hyperlipoproteidemia and hyperglicemia in males covered by the Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Szostak WB; Rywik S; Wasowicz B; Magdoń M; Celiński A
    Przegl Lek; 1979; 36(10):743-8. PubMed ID: 515459
    [No Abstract]   [Full Text] [Related]  

  • 8. [A characterization of the population included in the primary prevention of coronary heart disease programme (author's transl)].
    Sznajd J; Rywik S; Pach J; Magdon M; Janus T; Olszanecki S
    Przegl Lek; 1975; 32(6):519-24. PubMed ID: 1144819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology of cardiovascular diseases in Poland and the results of the Polish Experiment with regard to the multifactorial prevention of ischemic heart disease conducted in Warsaw and Southern Poland].
    Rywik S; Sznajd J
    Kardiol Pol; 1982; 25(10-11):967-81. PubMed ID: 6985151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes mellitus and ischaemic heart disease in male population of Warsaw factories (author's transl)].
    Przestalska-Malkin H; Rywik S
    Przegl Lek; 1981; 38(11):831-5. PubMed ID: 7335885
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polish experiment in the prevention of ischemic heart disease. V. Prevalence of coronary disease risk in a male population in Warsaw industrial plants].
    Charzewska J; Rywik S; Chabros E; Wagrowska H; Chotkowska E
    Kardiol Pol; 1980; 23(3):185-93. PubMed ID: 7373969
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polish experiment with regard to coronary disease prevention. IV. Incidence of ischemic heart disease among male population aged 40-59 from the Warsaw industrial plants participating in the experiment].
    Rywik S; Kuźmińska A; Charzewska J; Chabros E; Wagrowska H; Przestalska-Malkin H
    Kardiol Pol; 1980; 23(1):73-81. PubMed ID: 7366075
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polish experiment with regard to coronary disease prevention. III. Arterial hypertension and the effectiveness of its treatment among the male population aged 40-59 years from the Warsaw industrial plants participating in the experiment: Characteristics of the group of persons with hypertension].
    Rywik S; Przestalska-Malkin H; Charzewska J; Chabros E; Wagrowska H
    Kardiol Pol; 1980; 23(1):61-71. PubMed ID: 7366074
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of health status of male population aged 20--39 years employed in warsaw factories with special reference to ihd risk factors level (author's transl)].
    Kuźmińska A; Polakowska M; Przestalska-Malkin H; Kupśc W; Rywik S
    Przegl Lek; 1981; 38(11):787-91. PubMed ID: 7335877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polish experiment with regard to coronary disease prevention. II. Arterial hypertension and the effectiveness of its treatment among the male population of the Warsaw industrial plants participating in the experiment: arterial blood pressure].
    Rywik S; Przestalska-Malkin H; Charzewska J; Chabros E; Wagrowska H
    Kardiol Pol; 1980; 23(1):51-9. PubMed ID: 7366073
    [No Abstract]   [Full Text] [Related]  

  • 16. [The methodological principles of the active prevention conducted within the framework of "the Polish trial" of the primary prevention of I.H.D (author's transl)].
    Rywik S; Szostak W; Mikołajczyk W; Bién S; Korsak A; Charzewska J; Neklanda-Trepka A; Kulesza W; Sznajd J; Szybiński Z; Szczeklik A; Mellibruda L; Magdoń M; Koblik T; Pach J; Wasowicz B
    Przegl Lek; 1976; 33(6):568-75. PubMed ID: 959604
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of chronic nonspecific diseases of the respiratory system in male population covered by programme for prevention of coronary heart disease (author's transl)].
    Gałuszka Z; Pach J; Magdon M; Glinka W; Kulig E; Kulig J
    Przegl Lek; 1976; 33(6):639-43. PubMed ID: 959618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood pressure values in men included in prevention of coronary heart disease (author's transl)].
    Kawecka-Jaszczowa K; Szczeklik J; Mysik M; Miłkowski A
    Przegl Lek; 1976; 33(6):623-8. PubMed ID: 959615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of cholesterol assessment in a male population (author's transl)].
    Sznajd J; Szczeklik A; Wasowicz B; Pyska B; Zubik B; Magdoń M; Adamus W
    Przegl Lek; 1976; 33(6):605-10. PubMed ID: 959612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Incidence of ECG abnormalities in a male population (author's transl)].
    Wójcikiewicz O; Szczeklik J; Mysik M; Piwowarska W; Koczorowska S; Banak D
    Przegl Lek; 1976; 33(6):628-33. PubMed ID: 959616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.